论文信息 - Efficacy and safety of risankizumab for active psoriatic arthritis: 52-week results from the KEEPsAKE 2 study - 字舞流文

Efficacy and safety of risankizumab for active psoriatic arthritis: 52-week results from the KEEPsAKE 2 study

A. Soliman | K. Papp | A. Östör | A. Kivitz | F. E. Van den Bosch | Zailong Wang | A. Eldred | J. Aelion | B. Padilla | C. Asnal | Wenjing Lu | R. Blanco